Biotech & Medtech
Biotech & Medtech news — Friday 30 October 2026
18 stories from 3 sources, every one in English. Each links to its publisher.
-
Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs
MedCity News
The Department of Labor finalized a rule that seeks to bring more transparency into PBM compensation. The post Employer, Pharmacy Advocates Applaud DOL Final Rule on PBMs appeared first on MedCity News .
-
Bambusa IPO Brings In $169M to Break Immunology’s ‘Therapeutic Ceiling’
MedCity News
Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently available monoclonal antibodies. Aspen Neuroscience also debuted on the Nasdaq as it prepares for a pivotal test…
-
This week in charts: ESMO’s winners and losers
BioPharma Dive
The latest installment in BioPharma Dive’s visualization-focused series looks at Wall Street’s response to a trio of closely watched presentations at a top meeting for cancer drugs.
-
STAT+: Up and down the ladder: The latest comings and goings
STAT News
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them . Don’t be shy…
-
How Election Day can affect your heart
STAT News
The reminders to vote in Tuesday’s midterms are ubiquitous. Some health scholars have another reminder: that elections, especially divisive ones, can stress the heart. Studies have found a significantly higher chance of arrhythmias in the…
-
It’s A TRAP! Employer Concerns for Tuition Reimbursement and Other Employee Repayment Agreements
MedCity News
For life science employers who offer these benefits should pay particular attention to new state laws and regulations to ensure continued compliance. The post It’s A TRAP! Employer Concerns for Tuition Reimbursement and Other Employee…
-
A Meaningful Signal on Palliative Care – But Not Yet a Benefit
MedCity News
CMS asked the right questions – the ones that will determine whether any future benefit actually reaches these patients. The post A Meaningful Signal on Palliative Care – But Not Yet a Benefit appeared first on MedCity News .
-
Assessing Merck and Moderna’s mRNA cancer vaccine
STAT News
What is Adam doing in Spain? How did doctors react to detailed data on Merck and Moderna’s mRNA cancer vaccine ? And what are the next big advances in oncology? On this week’s episode of “The Readout LOUD,” STAT’s biotech podcast, we bring…
-
STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more
STAT News
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We will manicure the Pharmalot…
-
The persisting paradox of men’s health
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Buongiorno! As you put the final touches on your Halloween costumes, here is a spooky story for you: Imagine going to…
-
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
BioPharma Dive
Lilly’s better-than-expected results allayed concerns — for now — over GLP-1 pricing pressure. Elsewhere, Novartis withstood a tumultuous quarter and GSK battled investor angst.
-
With Setara, the team behind Actio opens its second act
BioPharma Dive
The fledgling startup has $90 million to develop a pipeline of drugs, led by a Charcot-Marie-Tooth disease medicine, that Actio was working on when Jazz Pharmaeuticals bought its lead epilepsy program.
-
The health care issues STAT reporters are watching in the midterms
STAT News
For this week’s “STATus Report,” I report from arguably the birthplace of American democracy, and my hometown, Boston. What better place is there to be ahead of next week’s midterm elections ? In this episode, STAT reporters from our D.C…
-
STAT+: How a simple UTI turns into a $1,756 bill
STAT News
It was a simple urinary tract infection. A textbook urgent care visit. Kristin Gills knew the drill. She peed in the cup, and the doctor confirmed her suspicion. He prescribed antibiotics. Before she left Methodist Legacy ER & Urgent Care…
-
Opinion: How Congress can fix expert advisory committees
STAT News
In September, Health and Human Services Secretary Robert F. Kennedy Jr. fired the two vice chairs of the U.S. Preventive Services Task Force. This move was both unsurprising and troubling. The task force is a critical advisory body to HHS…
-
STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
STAT News
Health officials hoping to boost adoption of artificial intelligence in health care have been moving behind the scenes to address brewing conflict between states and the federal government over the technology. The Trump administration has…
-
Opinion: What a mother’s 1834 letter about measles tells us about MAHA
STAT News
On Sept. 23, I sat in a small glass reading room at Yale’s medical library, turning the rag-paper pages of the Medical Dissenter, a London journal from the 1830s. At the bottom of one page, under the headline, “Report from Mrs. Butt to Mr…
-
Aspen raises a $140M IPO in pursuit of a cell therapy for Parkinson’s
BioPharma Dive
The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.